October 22, 2020

Advertising condoms: No need to request prior authorization from the Ministry of Health

The rules on advertising condoms are expected to change in the next few days. On October 6, Vice-Minister of Health Pierpaolo Sileni signed a decree allowing condoms to be advertised without prior authorization from the Ministry of Health. The decree has not been published in the Official Journal (Gazzetta Ufficiale) yet and will become applicable 15 days after publication.

Condoms are considered medical devices and, as such, the related advertising to the public must be duly authorized by the Ministry of Health pursuant to Article 21 of Legislative Decree No. 46 of February 24, 1997. From a practical standpoint, the authorization process may be very long. Indeed, for each advertisement, the company manufacturing condoms (or the company that places condoms on the market) must apply for authorization by submitting an application with information concerning the company itself, the advertised product, and the type of advertising and its means of dissemination (TV, social networks, billboards, etc.). In addition, a fee must be paid. The Ministry of Health has 45 days to evaluate the application and decide whether or not to authorize the advertising, with the option to request changes. If changes are requested, the company can either accept the proposed changes or reformulate the proposal: this makes the timeline for the procedure even longer. If the Ministry does not reply for 45 days, the advertising is considered tacitly approved (silenzio-assenso).

In light of this complex mechanism, in late January two members of Parliament sought to have these regulations revised, with the aim of improving and facilitating communication and information about the use of condoms. The logic was that citizens should be informed as best as possible in matters of sexuality using an aware and guided approach, as doing so protects citizens’ health. Bearing in mind that aim, on October 6 the Vice-Minister of Health signed a decree regarding condom advertising that has not yet been published in the Official Journal (Gazzetta Ufficiale). According to available information, the main provisions of the decree are as follows:

  • Condom advertising does not require the authorization of the Ministry of Health;
  • Even though authorization is no longer mandatory, manufacturers and distributors of condoms will continue to have the opportunity – if they wish – to apply for authorization in connection with the advertising;
  • If condom advertising presents information that may pose a risk to consumers’ health, the Ministry of Health is entitled to order (i) that advertising cease immediately, and (ii) publication at the offender’s expense of a statement rectifying and clarifying the information.

The decree will become applicable 15 days after its publication in the Official Journal (Gazzetta Ufficiale).

[1] The content of this article is based on the information available on October 22, 2020.

< Back to blog
Welcome to the Portolano Cavallo Life Sciences blog focusing on legal development and key legal issues affecting the life sciences and healthcare industry.
Read more
Our highly-ranked team of professionals will provide news, insights and multidisciplinary commentary on the hottest and most recent regulatory, transactional and contentious aspects of the pharmaceutical, bio-tech, med-tech, food supplement and healthcare world with an eye on its digital transformation and technological developments.

This blog will be a place for focusing on digital health, telemedicine and artificial intelligence, as well as more traditional topics: from the protection of intellectual properties to performance of clinical trials, from the market access to advertising and competition issues, from internal and criminal investigations to M&A and venture capital transactions.

March 20, 2023
Today, Regulation (EU) 2023/607 extending the transitional provisions for the placing on the market and putting into service of certain medical devices and in vitro diagnostic medical device...
January 31, 2023
Clinical trials: Ministry of Health signed off on decrees that (i) reorganize ethics committees and coordinate their activities, (ii) determine the single tariff for the authorization proced...
December 19, 2022
On 13 December 2022, EMA, European Commission and HMA jointly adopted a recommendation paper on the introduction of decentralised elements in the conduct of Clinical Trials in the EU/EEA
September 21, 2022
Payback for medical devices: Decree quantifying the exceeding of the expenditure ceiling for medical devices at national and regional level for the years 2015, 2016, 2017 and 2018 published ...
September 1, 2022
The 2021 annual law for market and competition addressing, as to the healthcare sector, reimbursement of drugs, intermediate distribution, patent linkage and institutional accreditation of p...
Search by...
Follow us on
Follow us on